Inside Drug Pricing - 04/08/2019

Senate Passes First Drug-Pricing Bill Of Session, Next Stop Trump’s Desk

April 02, 2019
The Senate on Tuesday (April 2) passed a bill to stop drug companies from avoiding Medicaid rebates by misclassifying brand drugs as generics, sending the first drug-pricing bill of this Congress to the president’s desk. The bipartisan Right Rebate Act was included in a larger Medicaid package that also included provisions that would provide an additional $20 million to the Money Follows the Person demonstration, and create a state option for health homes for children with medically complex conditions, previously...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.